Beyond Air, Inc. (XAIR) Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors

Go back to Beyond Air, Inc. (XAIR) Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors
(NASDAQ: XAIR) Delayed: 3.09 +0.01 (0.32%)
Previous Close $3.08    52 Week High
Open $3.07    52 Week Low
Day High $3.26    P/E N/A 
Day Low $3.07    EPS
Volume 38,844